KTTA RSI Chart
Last 7 days
-4.7%
Last 30 days
4.6%
Last 90 days
-0.1%
Trailing 12 Months
-20.3%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 0 | 0 | 604.6K | 763.9K |
2022 | 0 | 0 | 0 | 486.6K |
2021 | 0 | 0 | 0 | 0 |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Jun 02, 2023 | steinman lawrence | bought | 12,930 | 0.431 | 30,000 | - |
Nov 28, 2022 | steinman lawrence | acquired | 4,900 | 0.98 | 5,000 | - |
Nov 25, 2022 | marques tiago | acquired | 2,060 | 1.03 | 2,000 | chief executive officer |
Nov 23, 2022 | marques tiago | acquired | 7,260 | 1.00751 | 7,206 | chief executive officer |
Nov 22, 2022 | steinman lawrence | acquired | 4,950 | 0.99 | 5,000 | - |
Nov 17, 2022 | dumesnil simon | acquired | 42,400 | 1.06 | 40,000 | - |
Nov 15, 2022 | dumesnil simon | acquired | 10,700 | 1.07 | 10,000 | - |
Oct 26, 2022 | steinman lawrence | acquired | 5,500 | 1.1 | 5,000 | - |
Oct 21, 2022 | marques tiago | acquired | 5,356 | 1.0712 | 5,000 | chief executive officer |
Oct 17, 2022 | delaney david | bought | 1,110 | 1.11 | 1,000 | - |
Which funds bought or sold KTTA recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Feb 26, 2024 | Virtu Financial LLC | sold off | -100 | -7,000 | - | -% |
Feb 26, 2024 | Virtu Financial LLC | sold off | -100 | -1,000 | - | -% |
Feb 15, 2024 | JANE STREET GROUP, LLC | new | - | 8,728 | 8,728 | -% |
Feb 14, 2024 | CLEAR STREET LLC | sold off | -100 | - | - | -% |
Feb 14, 2024 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | sold off | -100 | -18,501 | - | -% |
Feb 14, 2024 | Royal Bank of Canada | unchanged | - | - | 2,000 | -% |
Feb 14, 2024 | CITADEL ADVISORS LLC | added | 2.17 | 46.00 | 236 | -% |
Feb 13, 2024 | GEODE CAPITAL MANAGEMENT, LLC | unchanged | - | -11,232 | 48,824 | -% |
Feb 13, 2024 | NORTHERN TRUST CORP | new | - | 17,417 | 17,417 | -% |
Feb 13, 2024 | XTX Topco Ltd | sold off | -100 | -5,145 | - | -% |
Unveiling Pasithea Therapeutics Corp.'s Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Pasithea Therapeutics Corp.)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 41.2B | 6.8B | -8.75 | 6.02 | ||||
HILS | 22.4B | 152.6K | -2.4K | 146.8K | ||||
ALNY | 18.0B | 1.8B | -41 | 9.87 | ||||
BMRN | 15.4B | 2.5B | 74.73 | 6.21 | ||||
INCY | 11.6B | 3.7B | 19.41 | 3.14 | ||||
MID-CAP | ||||||||
APLS | 6.0B | 396.6M | -11.37 | 15.16 | ||||
BBIO | 4.4B | - | -6.7 | 60.35 | ||||
AXSM | 3.4B | 270.6M | -14.22 | 12.57 | ||||
ACAD | 2.8B | 726.4M | -44.9 | 3.79 | ||||
ARWR | 2.7B | 240.7M | -9.23 | 12.18 | ||||
SMALL-CAP | ||||||||
CPRX | 1.8B | 398.2M | 24.58 | 4.41 | ||||
NVAX | 569.6M | 983.7M | -1.05 | 0.58 | ||||
CRBP | 361.2M | 881.7K | -8.1 | 466.16 | ||||
INO | 247.0M | 4.9M | -1.83 | 50.76 | ||||
IBIO | 6.1M | 2.1M | -0.22 | 2.14 |
Pasithea Therapeutics Corp. News
Income Statement (Quarterly) | |||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 |
Revenue | 31.2% | 172,825 | 131,740 | 240,712 | 218,608 | 13,581 | 1,609,054 | 3,204,527 | 4,800,000 |
Gross Profit | - | - | - | - | 132,143 | -1,520 | 721 | - | - |
S&GA Expenses | -17.0% | 1,797,234 | 2,164,560 | 2,656,305 | 2,576,802 | 2,611,559 | 2,078,878 | 1,954,044 | 1,273,600 |
R&D Expenses | 106.3% | 3,351,548 | 1,624,766 | - | 1,278,922 | - | - | - | - |
EBITDA Margin | 26.6% | -20.28 | -27.61 | -28.58 | - | - | - | - | - |
Interest Expenses | - | - | - | - | - | - | - | - | -508 |
Earnings Before Taxes | -39.3% | -5,031,264 | -3,612,590 | -4,053,404 | -4,191,041 | -2,189,859 | -1,293,581 | 630,143 | -1,526,108 |
EBT Margin | 26.7% | -20.30 | -27.68 | -28.64 | - | - | - | - | - |
Net Income | -39.7% | -5,048,159 | -3,612,590 | -5,117,688 | -4,586,130 | -2,658,394 | -1,574,240 | 630,143 | -1,526,108 |
Net Income Margin | 21.2% | -20.90 | -26.51 | -28.64 | - | - | - | - | - |
Free Cashflow | -2.5% | -3,294,308 | -3,215,186 | -6,213,255 | -4,627,080 | -1,942,366 | -2,154,109 | - | - |
Balance Sheet | ||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2020Q4 |
Assets | -14.8% | 26,117 | 30,657 | 38,149 | 42,045 | 45,180 | 49,608 | 53,028 | 51,079 | 53,321 | 21,042 | - |
Current Assets | -19.6% | 16,692 | 20,771 | 28,037 | 31,113 | 34,077 | 44,469 | 48,614 | 50,950 | 53,300 | 21,034 | 248 |
Cash Equivalents | -16.8% | 16,300 | 19,585 | 26,648 | 29,914 | 33,088 | 42,380 | 47,896 | 50,321 | 52,902 | 20,565 | 244 |
Net PPE | -3.2% | 141 | 146 | 173 | 175 | 125 | 341 | 170 | 129 | 20.00 | 9.00 | - |
Goodwill | 0% | 1,263 | 1,263 | 1,263 | 1,263 | 1,263 | 3,854 | 3,833 | - | - | - | - |
Liabilities | 19.0% | 2,718 | 2,284 | 2,559 | 2,910 | 2,682 | 2,819 | 1,554 | 1,101 | 1,900 | 4,567 | - |
Current Liabilities | 28.9% | 2,634 | 2,044 | 2,229 | 2,122 | 1,878 | 1,514 | 950 | 434 | 447 | 528 | 7.00 |
Shareholder's Equity | -17.5% | 23,398 | 28,374 | 35,590 | 39,135 | 42,498 | 46,789 | 51,322 | 49,977 | 51,421 | 16,475 | 241 |
Retained Earnings | -16.7% | -35,318 | -30,270 | -26,657 | -22,894 | -19,356 | -11,033 | -6,447 | -3,788 | -2,214 | -2,844 | -40.98 |
Additional Paid-In Capital | 0.1% | 58,722 | 58,634 | 62,233 | 62,015 | 61,856 | 57,951 | 57,967 | 53,764 | 53,628 | 19,307 | 267 |
Shares Outstanding | 0.0% | 1,042 | 1,042 | 1,307 | 1,306 | 1,302 | 1,327 | 1,161 | 1,150 | 1,150 | 422 | 373 |
Float | - | - | - | 10,500 | - | - | - | 19,400 | - | - | - | - |
Cashflow (Quarterly) | |||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 |
Cashflow From Operations | -1.7% | -3,294 | -3,237 | -3,079 | -3,202 | -3,185 | -4,621 | -1,935 | -2,152 | -1,744 | -548 | -499 | -381 | - | - |
Share Based Compensation | -44.8% | 70.00 | 127 | 219 | 177 | 156 | -16.07 | 559 | 136 | - | - | - | - | - | - |
Cashflow From Investing | 8.7% | 55.00 | 50.00 | 24.00 | -53.89 | -2,341 | -25.97 | 70.00 | -1.95 | - | - | - | - | - | - |
Cashflow From Financing | 100.0% | - | -3,859 | -130 | 264 | - | - | - | - | 34,165 | 20,555 | - | 1,209 | - | - |
Buy Backs | -100.0% | - | 3,726 | - | - | - | - | - | - | - | - | - | - | - | - |
Consolidated Statements of Operations and Comprehensive Loss - USD ($) | 12 Months Ended | |
---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | |
Operating expenses: | ||
General and administrative | $ 7,878,596 | $ 9,923,544 |
Research and development | 8,100,765 | 2,665,427 |
Loss from operations | (15,979,361) | (12,588,971) |
Other income (expense): | ||
Change in fair value of warrant liabilities | 56,245 | 1,852,189 |
Interest and dividends, net | 415,368 | |
Gain on forgiveness of accounts payable | 10,633 | |
Litigation settlements | (1,001,736) | |
Other income, net | 471,613 | 861,086 |
Loss before income taxes | (15,507,748) | (11,727,885) |
Provision for income taxes | ||
Net loss from continuing operations | (15,507,748) | (11,727,885) |
Net loss from discontinued operations, net of tax | (453,910) | (2,208,567) |
Net loss | $ (15,961,658) | $ (13,936,452) |
Weighted-average common shares outstanding, basic (in Shares) | 1,226,600 | 1,262,339 |
Basic net loss per share from continuing operations (in Dollars per share) | $ (12.64) | $ (9.29) |
Basic net loss per share from discontinuing operations (in Dollars per share) | $ (0.37) | $ (1.74) |
Comprehensive loss: | ||
Net loss | $ (15,961,658) | $ (13,936,452) |
Foreign currency translation | (3,991) | 9,900 |
Comprehensive loss | $ (15,965,649) | $ (13,926,552) |
Consolidated Balance Sheets - USD ($) | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 16,331,052 | $ 33,087,864 |
Amount due from sale of assets | 40,500 | |
Prepaid expenses | 215,895 | 562,375 |
Other current assets | 104,707 | 262,992 |
Current assets of discontinued operations | 163,462 | |
Total current assets | 16,692,154 | 34,076,693 |
Property and equipment, net | 141,208 | 125,197 |
Right of use asset- operating lease | 79,271 | 500,428 |
Intangibles, net | 7,941,314 | 8,571,478 |
Goodwill | 1,262,911 | 1,262,911 |
Non-current assets of discontinued operations | 643,382 | |
Total assets | 26,116,858 | 45,180,089 |
Current liabilities: | ||
Accounts payable and accrued liabilities | 2,552,360 | 1,481,393 |
Lease liability- short term portion | 81,680 | 160,362 |
Current liabilities of discontinued operations | 235,879 | |
Total current liabilities | 2,634,040 | 1,877,634 |
Non-current liabilities | ||
Lease liability | 344,021 | |
Warrant liabilities | 84,366 | 140,611 |
Non-current liabilities of discontinued operations | 319,575 | |
Total non-current liabilities | 84,366 | 804,207 |
Total liabilities | 2,718,406 | 2,681,841 |
Commitments and Contingencies | ||
Stockholders’ equity: | ||
Preferred stock, par value $0.0001, 5,000,000 shares authorized; 0 issued and outstanding | ||
Common stock, par value $0.0001, 100,000,000 shares authorized; 1,041,582 and 1,301,921 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively | 104 | 130 |
Additional paid-in capital | 58,721,538 | 61,855,659 |
Accumulated other comprehensive loss | (4,652) | (661) |
Accumulated deficit | (35,318,538) | (19,356,880) |
Total stockholders’ equity | 23,398,452 | 42,498,248 |
Total liabilities and stockholders’ equity | $ 26,116,858 | $ 45,180,089 |